Search Results - "Vertongen, Pascale"

Refine Results
  1. 1
  2. 2
  3. 3

    Binding characteristics of [ 3H]ucb 30889 to levetiracetam binding sites in rat brain by Gillard, Michel, Fuks, Bruno, Michel, Philippe, Vertongen, Pascale, Massingham, Roy, Chatelain, Pierre

    Published in European journal of pharmacology (30-09-2003)
    “…Levetiracetam (2 S-(2-oxo-1-pyrrolidinyl)butanamide, KEPPRA®), a novel antiepileptic drug, has been shown to bind to a specific binding site located in brain…”
    Get full text
    Journal Article
  4. 4

    Contribution of the Carboxyl Terminus of the VPAC1 Receptor to Agonist-induced Receptor Phosphorylation, Internalization, and Recycling by Langlet, Christelle, Langer, Ingrid, Vertongen, Pascale, Gaspard, Nathalie, Vanderwinden, Jean-Marie, Robberecht, Patrick

    Published in The Journal of biological chemistry (29-07-2005)
    “…When exposed to vasoactive intestinal peptide (VIP), the human wild type VPAC1 receptor expressed in Chinese hamster ovary (CHO) cells is rapidly…”
    Get full text
    Journal Article
  5. 5

    Two Basic Residues of the h-VPAC1 Receptor Second Transmembrane Helix Are Essential for Ligand Binding and Signal Transduction by Solano, Rosa Maria, Langer, Ingrid, Perret, Jason, Vertongen, Pascale, Juarranz, Maria Guillerma, Robberecht, Patrick, Waelbroeck, Magali

    Published in The Journal of biological chemistry (12-01-2001)
    “…We mutated the vasoactive intestinal peptide (VIP) Asp3 residue and two VPAC1receptor second transmembrane helix basic residues (Arg188and Lys195). VIP had a…”
    Get full text
    Journal Article
  6. 6

    Development of high affinity selective VIP1 receptor agonists by Gourlet, P, Vandermeers, A, Vertongen, P, Rathe, J, De Neef, P, Cnudde, J, Waelbroeck, M, Robberecht, P

    Published in Peptides (New York, N.Y. : 1980) (1997)
    “…The biological effects of VIP are mediated by at least two VIP receptors: the VIP1 and the VIP2 receptors that were cloned in rat, human and mice. As the mRNA…”
    Get full text
    Journal Article
  7. 7

    Autoradiographic Visualization of the Receptor Subclasses for Vasoactive Intestinal Polypeptide (VIP) in Rat Brain by Vertongen, Pascale, Schiffmann, Serge N, Gourlet, Philippe, Robberecht, Patrick

    Published in Peptides (New York, N.Y. : 1980) (1997)
    “…Vertongen, P., S. N. Schiffmann, P. Gourlet and P. Robberecht. Autoradiographic visualization of the receptor subclasses for Vasoactive Intestinal Polypeptide…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Osteonecrosis of the Femoral Head: Lipotoxicity Exacerbation in MSC and Modifications of the Bone Marrow Fluid by Gillet, Celine, Dalla Valle, Antoine, Gaspard, Nathalie, Spruyt, Delphine, Vertongen, Pascale, Lechanteur, Jessica, Rigutto, Sabrina, Dragan, Elena-Raluca, Heuschling, Audrey, Gangji, Valerie, Rasschaert, Joanne

    Published in Endocrinology (Philadelphia) (01-03-2017)
    “…Osteonecrosis of the femoral head (ON) is a multifactorial bone disease that can evolve to a progressive destruction of the hip joint. Different pathogenic…”
    Get full text
    Journal Article
  10. 10

    Analysis of the glucagon receptor first extracellular loop by the substituted cysteine accessibility method by Roberts, David J., Vertongen, Pascale, Waelbroeck, Magali

    Published in Peptides (New York, N.Y. : 1980) (01-08-2011)
    “…[Display omitted] ► SCAM of the first glucagon receptor extracellular loop (197–224). ► TM2 continues to position 202, TM3 from 215 ► Most side chains…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Differential alternative splicing of PACAP receptor in pituitary cell subpopulations by Vertongen, Pascale, Velkeniers, Brigitte, Hooghe-Peters, Elisabeth, Robberecht, Patrick

    Published in Molecular and cellular endocrinology (22-09-1995)
    “…The capability of rat pituitary cells to express receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and VIP was evaluated by binding…”
    Get full text
    Journal Article
  13. 13

    Mutational and Cysteine Scanning Analysis of the Glucagon Receptor N-terminal Domain by Prévost, Martine, Vertongen, Pascale, Raussens, Vincent, Roberts, David Jonathan, Cnudde, Johnny, Perret, Jason, Waelbroeck, Magali

    Published in The Journal of biological chemistry (01-10-2010)
    “…The glucagon receptor belongs to the B family of G-protein coupled receptors. Little structural information is available about this receptor and its…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Characterization of [3H]ucb 30889 binding to synaptic vesicle protein 2A in the rat spinal cord by Lambeng, Nathalie, Gillard, Michel, Vertongen, Pascale, Fuks, Bruno, Chatelain, Pierre

    Published in European journal of pharmacology (27-09-2005)
    “…The novel antiepileptic drug levetiracetam ((2S-(2-oxo-1-pyrrolidinyl)butanamide, KEPPRA®) possesses a specific binding site in brain, which has very recently…”
    Get full text
    Journal Article
  16. 16

    Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas by Langer, Ingrid, Vertongen, Pascale, Perret, Jason, Fontaine, Jeanine, Atassi, Ghanem, Robberecht, Patrick

    Published in Medical and pediatric oncology (01-06-2000)
    “…Background Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen that stimulates angiogenesis and plays a crucial role in tumor…”
    Get full text
    Journal Article
  17. 17

    Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines by Fuks, Bruno, Gillard, Michel, Michel, Philippe, Lynch, Berkley, Vertongen, Pascale, Leprince, Pierre, Klitgaard, Henrik, Chatelain, Pierre

    Published in European journal of pharmacology (30-09-2003)
    “…Levetiracetam (2 S-(2-oxo-1-pyrrolidinyl)butanamide, KEPPRA®), a novel antiepileptic drug, has been shown to bind to a specific binding site located in the…”
    Get full text
    Journal Article Web Resource
  18. 18

    Motilin and erythromycin-A share a common binding site in the third transmembrane segment of the motilin receptor by Xu, Luo, Depoortere, Inge, Vertongen, Pascale, Waelbroeck, Magali, Robberecht, Patrick, Peeters, Theo L.

    Published in Biochemical pharmacology (15-09-2005)
    “…The motilin receptor (MTLR) represents a clinically useful pharmacological target, as agonists binding to the MTLR have gastroprokinetic properties. In order…”
    Get full text
    Journal Article
  19. 19

    A Small Sequence in the Third Intracellular Loop of the VPAC1 Receptor Is Responsible for Its Efficient Coupling to the Calcium Effector by Langer, Ingrid, Vertongen, Pascale, Perret, Jason, Waelbroeck, Magali, Robberecht, Patrick

    Published in Molecular endocrinology (Baltimore, Md.) (01-05-2002)
    “…The stimulatory effect of VIP on intracellular calcium concentration ([Ca2+]i) has been investigated in Chinese hamster ovary cells stably transfected with the…”
    Get full text
    Journal Article
  20. 20

    Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27) - a VPAC1 receptor antagonist: is an inverse agonist on two constitutively active truncated VPAC1 receptors by VERTONGEN, Pascale, LANGLET, Christelle, LANGER, Ingrid, GASPARD, Nathalie, ROBBERECHT, Patrick

    Published in Peptides (New York, N.Y. : 1980) (01-11-2004)
    “…C-terminally truncated human VPAC(1) receptors were constructed and stably transfected in Chinese hamster ovary (CHO) cells. Selected clones expressing…”
    Get full text
    Journal Article